Publications

1. Adeleye OO, Ogbera AO, Fasanmade O, Ogunleye OO, Dada AO, Ale AO, Abatan FM. Latent Autoimmune Diabetes Mellitus in Adults (LADA) and it’s characteristics in a subset of Nigerians initially managed for type 2 diabetes. Int Arch Med. 2012 Aug 15;5(1):23. [Epub ahead of print]

2. Doumatey AP, Zhou J, Huang H, Adeleye J, Balogun W, Fasanmade O et al. Circulating adiponectin is associated with renal function independent of age and serum lipids in West Africans. Int J Nephrol 2012 doi:10.1155/2012/730920

3. Doumatey AP, Chen G, Tekola Ayele F, Zhou J, Erdos M, Shriner D, Huang H, Adeleye J, Balogun W, Fasanmade O, Johnson T, Oli J, Okafor G, Amoah A, Eghan BA, Agyenim-Boateng K, Acheampong J, Adebamowo C, Gerry NP, Christman MF, Adeyemo A, Rotimi CN. C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans. Hum Mol Genet. 2012; 21(13):3063-72.

4. Chinenye S, Uloko AE, Ogbera AO, Ofoegbu EN, Fasanmade OA, Fasanmade AA, Ogbu OO. Profile of Nigerians with diabetes mellitus – Diabcare Nigeria study group (2008): Results of a multicenter study. Indian J Endocrinol Metab. 2012;16(4):558-64

5. Oluyemi A, Anomneze E, Smith S, Fasanmade O. Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria. BMC Research Notes 2012: 5(1)284

6. Tekola Ayele F, Doumatey A, Huang H, Zhou J, Charles B, Erdos M, Adeleye J, Balogun W, Fasanmade O, Johnson T, Oli J, Okafor G, Amoah A, Eghan BA Jr, Agyenim-Boateng K, Acheampong J, Adebamowo CA, Herbert A, Gerry N, Christman M, Chen G, Shriner D, Adeyemo A, Rotimi CN. Genome-wide associated loci influencing interleukin (IL)-10, IL-1Ra, and IL-6 levels in African Americans. Immunogenetics. 2011 Dec 29. [Epub ahead of print]

7. Okafor CI, Fasanmade O, Ofoegbu E, Ohwovoriole AE. Comparison of the performance of two measures of central adiposity among apparently healthy Nigerians using the receiver operating characteristic analysis. Indian J Endocrinol Metab. 2011;15(4):320-6

8. Babagana Gutti, Alfred A. Susu, Fasanmade O. A. Mathematical modelling and software application of blood flow for therapeutic management of stroke. International Journal of Mathematical Science, Vol 3, Number 1, 2011

9. Ogbera AO, Chinenye S, Fasanmade O, Ajala W (2011).Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus. Journal of the College of Physicians and Surgeons in Pakistan 2011 Sep:21(9):517-21.

10. Odeniyi IA, Fasanmade OA, Ajala MO, Ohwovoriole AE (2011). Adrenocortical function in Nigerian patients with pulmonary tuberculosis (PTB). Afr J Med Med Sci 40:33-38

11. Isezuo SA, Sabir AA, Ohwovoriole AE, Fasanmade OA (2011), Prevalence associated factors and relationship between pre-hypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. J Hum Hypertension 25(4):224-30

12. Odeniyi IA, , Fasanmade OA, Ajala MO, Ohwovoriole AE (2010), Comparison of low dose and standard dose adrenocorticotrophin stimulation tests in health Nigerians. Afr J Med Sci 39(2) 113-118

13. Gutti B, Susu A A, Fasanmade OA (2010), Mathematical Modeling and Numerical Simulation of blood flow in distensible blood vessels. International Journal of Engineering Vol. 4, No 2(2010) 129-142

14. Ogbera AO, Fasanmade OA, Kalra S.(2010) Menopausal symptoms and the metabolic syndrome in Nigerian women with type 2 Diabetes Mellitus. Climacteric 2011 feb:14(1):75-82 Epub 2010 Feb 12

15. Doumatey AP, Lashley KS, Huang H, Zhou J, Chen G, Amoah A, Agyenim-Boateng K, Oli J, Fasanmade OA, Adeyemo AA, Rotimi CN (2010). Relationship among obesity, inflammation and insulin resistance in African Americans and West Africans. (Silver spring) 18 (3): 598-603

16. Ogbera AO, Fasanmade OA, Chinenye S, Akinlade A (2009). Characterization of lipid parameters in diabetes mellitus: a Nigerian report. International Arch. Med 20;2(1):19

17. Ogbera AO, Awobusuyi J, Unachukwu C, Fasanmade OA (2009). Clinical features, predictive factors and outcome of hyperglycaemic emergencies in a developing country. BMC Endocrine Disorders. 2009 March 10;9:9

18. Ekpebegh CO, Iwuala SO, Fasanmade OA, Ogbera AO, Igumbor E, Ohwovoriole AE. (2009).Diabetes foot ulceration in a Nigerian hospital: In hospital mortality in relationship to the presenting present demographic, clinical and laboratory features. Int Wound J. 6(5); 381-5

19. Isiavwe AR, Ekpebegh CO, Fasanmade OA, Ohwovoriole AE (2008). Steroid responsive hypertension secondary to 11 beta hydroxylase deficiency. West African Journal of Medicine. 27(3):182-5 

20. Ogbera AO, Chinenye S, Onyekwere AC, Fasanmade OA (2007). Prognostic indices of diabetes mortality. Ethnicity and Disease. 17(4): 721-725

21. Chen Y, Huang H, Zhou J, Doumatey A, Lashley K, Chen G, Agyenim-Boateng K, Eghan BA, Acheampong J, Fasanmade OA, Johnson T, Akinsola FB, Okafor G, Oli J, Ezepue F, Amoah A, Akafo S, Adeyemo A, Rotimi CN (2007). Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Molecular Vision. 13:2142-7

22. Ogbera AO, Fasanmade OA, Isiba A (2007). The scope of cardiac complications of thyrotoxicosis in Lagos, Nigeria. Pakistan Journal of Medical Science. 23(5); 671-675.

23. Chen G, Adeyemo A, Zhou J, Chen Y, Doumatey A, Lashley K, Hung H, Amoah A, Agyenim-Boateng K, Benjamin A, Eghan Jr B, Okafor G, Acheampong J, Oli J, Fasanmade OA, Johnson T, and Rotimi C (2007). A Genome- Wide Search for Linkage to Renal Function Phenotypes in West Africans with Type 2 Diabetes. Am J Kidney Dis.49 (3) :394-400

24. Chen G, Adeyemo A, Zhou J, Chen Y.., Fasanmade O, Johnson T, Okafor G, Oli J, Amoah A, Rotimi C. (2007).Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: Potential role of C-peptide. Diabetes Res Clin Pract. 78(3) :e1-6

25. Ogbera AO, Fasanmade OA (2007). Pattern of thyroid disorders in South Western Nigeria. Ethnicity and Disease. 17(2) :327-330

26. Ogbera AO, Fasanmade OA, Ohwovoriole AE (2006). An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 5 (4): 244-249

27. Rotimi CN, Chen G, Adeyemo AA, Jones LS, Agyenim-Boateng K, Eghan BA Jr, Zhou J, Doumatey A, Lashley K, Huang H, Fasanmade OA, Akinsola FB, Ezepue F, Amoah A, Akafo S, Chen Y, Oli J, Johnson T (2006). Genome wide scan and fine mapping of quantitative trait loci for intra-ocular pressure on 5q and 14q in west Africans. Investigative Ophthalmology and Visual Science. 47(8): 3262-7

28. Ogbera AO, Adedokun A, Fasanmade OA, Ohwovoriole AE, Ajani M (2005). The foot at risk in Nigerians with diabetes mellitus- The Nigerian scenario. International Journal of Endocrinology and Metabolism. 4: 165-173

29. Bonilla C, Panguluri RK, Taliaferro-Smith l, Argyropoulos G, Chen G, Adeyemo AA, Amoah A, Owusu S, Acheampong J, Agyenim-Boateng K, Eghan BA, Oli J, Okafor G, Abbiyesuku F, Johnson T, Rufus T, Fasanmade OA, Chen Y, Collins FS, Dunston GM, Rotimi C, Kittles RA(2006). Agouti-related protein promoter variant associated with leanness and decreased risk for diabetes in West Africans. Int J Obes (London). 30(4),715-21

30. Adeyemo AA, Johnson T, Acheampong J, Oli J, Okafor G, Amoah A, Owusu S, Agyenim-Boateng K, Eghan BA Jr, Abbiyesuku F, Fasanmade OA, Rufus T, Doumatey A, Chen G, Zhou J, Chen Y, Fubert-Harris P, Dunston G, Collins F, Rotimi C (2005). A genome wide quantitative trait linkage analysis for serum lipids in type 2 diabetes in an African population. 181(2), 389- 97.

31. Chen Y, Kittles R, Zhou J, Chen G, Adeyemo A, Panguluri RK, Chen W, Amoah A, Opoku V, Acheampong J, Agyenim K, Eghan B, Nyantaki A, Oli J, Okafor G, Ofoegbu E, Osotimehin B, Abbiyesuku F, Johnson T, Fasanmade O A, Rufus T, Furbert P, Daniel H, Berg K, Collins F, Dunston G, Rotimi C (2005). Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: The Africa America Diabetes Mellitus (AADM) Study. Ann Epidemiol 15,153-159.

32. Rotimi CN, Chen G, Adeyemo AA, Furbert-Harris P, Guass D, Zhou J, Berg K, Adegoke O, Amoah A, Owusu S, Acheampong J, Agyenim-Boateng K, Eghan BA Jr., Oli J, Okafor G, Ofoegbu E, Osotimehin B, Abbiyesuku F, Johnson T, Rufus T, Fasanmade OA, Kittles R, Daniel H, Chen Y, Dunston G, Collins FS (2004). A genome-wide search for type 2 diabetes susceptibility genes in West Africans. Diabetes.53, 838-841.

33. Rotimi CN, Dunston GM, Berg K, Akinsete O, Boateng K, Oli J, Okafor G, Onyenekwe B, Osotimehin B, Abbiyesuku F, Johnson T, Fasanmade O A, Furbert-Harris P, Kittles R, Vekich M, Adegoke O, Bonney G, and Collins F (2001). In search of susceptibility genes for type 2 diabetes in West Africa: The design and results of the first phase of the AADM study. Ann Epidemiol .11: 51-58.

34. Rotimi C, Daniel H, Zhou J, Obisesan A, Chen G, Chen Y, Amoah A, Opoku V, Acheampong J, Agyenim-Boateng K, Eghan BA, Oli J, Okafor G, Ogoegbu E, Osotimehin B, Abbiyesuku F, Johnson T, Fasanmade OA, Doumatey A, Aje T, Collins F, Dunston G (2003). Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethnicity and Disease. 13: S2-110 – S2-117.

35. Ohwovoriole AE, Fasanmade OA, Johnson TO (1994). Assessment of diabetic control: An African perspective. International Diabetes Digest. 5:47-50.

(I) INDEXED NATIONAL JOURNALS

36. Okafor CI, Fasanmade OA, Oke DA (2008), Pattern of dyslipidaemia among Nigeria with type 2 diabetes mellitus. Niger J Clin Pract 11(1):25-31

37. Fasanmade OA, Odeniyi IA, Ogbera AO (2008). Diabetic ketoacidosis: diagnosis and management. African Journal of Medicine and Medical Sciences. 37(2):99-105

38. Osuntoki AA, Fasanmade OA, Adelaola AO, Amira CO (2007), Lipid peroxidation and erythrocyte fragility in poorly controlled type 2 diabetes mellitus. Nig Q J Hosp Med 17(4) 148-151

39. Fasanmade OA, Okubadejo NU (2007). Magnitude and gender distribution of obesity and abdominal adiposity in Nigerians with type 2 diabetes mellitus. Nigerian Journal of Clinical Practice. 10(1): 52 – 57

40. Ajuluchukwu JN, Okubadejo NU, Mabayoje M, Ojini FI, Okwudiafor RN, Mbakwem AC, Fasanmade OA, Oke DA (2007). Comparative study of the effects of tocotrienols and alpha tocopherol on fasting serum lipid profiles in Nigerians with mild hypercholesterolaemia. Nigerian Post Graduate Medical Journal.14 (1):30-33

41. Fasanmade OA. Odeniyi IA, Adeyemi Doro AO, Raimi TH, Adenegan JA (2007). Recent developments in the management of Diabetes Mellitus. Nigerian Journal of Clinical Practice. 2007:10(4):335-42.

42. Fasanmade OA, Osuntoki AA, Amira CO  (2007). Lipid peroxidation and erythrocyte fragility in poorly controlled type 2 diabetes mellitus. Nigeria Quarterly Journal of Hospital Medicine. 17(4):148-151

43. Coker AO, Fasanmade OA (2006). Quality of Care for patients with type 2 diabetes in Lagos University Teaching Hospital. Nigerian Quarterly Journal of Hospital Medicine. 16(1) :6-9

44. Ajala MO, Oladipo OO, Fasanmade OA, Adewole TA (2003). Laboratory assessment of three glucometers. African Journal Medicine and Medical Sciences. 32:279-282

(II) NON INDEXED NATIONAL JOURNALS

45. Adamu AN, Ohwovoriole AE, Fasanmade OA, Olarinoye JK, Ekpebegh CO. Relationship between HBA1c and 2 hour post glucose load as a screening tool for type 2 diabetes mellitus. Nigerian Endocrine Practice 2011:5(2): 6-11

46. Adamu NA, Ohwovoriole AE, Olarinoye JK, Fasanmade OA, Ekpebegh CO, Adebayo SB. Logistic Regression Equation of Diabetes Risk Score among Nigerians   International Journal of Microbiology

47. Fasanmade OA, Ekpebegh CO, Ogbera AO. The indications for hospitalization of people with diabetes and the outcomes; the experience of a secondary health centre in Lagos. Nigerian Endocrine practice 2008: 2;44 – 51

48. Ogbera AO, Fasanmade OA, Chinenye S, Onyekwere C (2007). Characterization of newly registered patients with diabetes mellitus in an outpatient facility in Nigeria. Nigerian Endocrine Practice. 1: 19-28

49. Odeniyi IA, Fasanmade OA, Ogbera AO (2007). Concomitant diabetes mellitus and tuberculosis as seen in Lagos, Nigeria. Nigerian Endocrine Practice. 1: 4-8

50. Coker AO, Fasanmade OA (2005). Supervised treatment with Glanil® and Glucoformin® obviates need for insulin therapy in patients with poorly controlled type 2 diabetes mellitus. Journal of Clinical Sciences. 5(1) 14-17

51. Fasanmade OA, Giwa SO, Kehinde MO, Ibidapo MO, Ajuluchukwu JN, Soyebi KO (2005). Doppler sonography in Nigerians investigated for deep vein thrombosis: a five – year review. Journal of Clinical Sciences. 5(2): 48-53

52. Okubadejo NU, Fasanmade OA (2004). Concomitant hypertension and type 2 diabetes in Nigerians: Prevalence of obesity and its indices compared to normotensive diabetics. Nigerian Medical Journal. 45: 79-83.

53. Jarikre AE, Fasanmade OA, Okosieme OE (2000). Plasma lipid levels and glucose concentrations in previously tablet controlled NIDDM patients and their relationship to cardiovascular morbidity. Nigerian Medical Journal. 38(2), 35-37.

(III) NON INDEXED INTERNATIONAL

54. IK Akhuemokhan, FO Ehusani-Anumah, AO Ogbera, RT Ikem, F Puepet, AO Adeyemi-Doro, A Eregie, OA Fasanmade, AE Ohwovoriole.    Hypertension in Nigerians with type 2 diabetes: a multicentre survey. Diabetes International 2008: May: 17 -18

55. Gutti B, Susu A, Fasanmade OA. Mathematical Modeling and Software Application of Blood Flow for Therapeutic Management of Stroke. Engineering, 2012, 4, 228-233 doi:10.4236/eng.2012.44030 Published Online April 2012 http://www.SciRP.org/journal/eng)

56. Gutti B, Susu AA and Fasanmade OA (2010). Mathematical Modeling and Numerical Simulation of Glucose-Insulin System for Diabetic Therapeutic Management. Research Journal of Applied Sciences 5(1): 1-6

57. Gutti B, Susu AA, Fasanmade OA. (2010) Mass transport in transport in arteries and the localization of atherosclerosis in Humans. Intern J Engineering and Applied Sciences ;2:53-62

58. Bentley AR, Doumatey A………Fasanmade O. Variation in APOL 1 contributes to ancestry level differences in HDL –C kidney function association. Int J Nephrol 2012

Odeniyi I.A, Fasanmade O.A. Urinary free cortisol. How useful? Nigerian Journal of Clinical Practice 2012

1. Dr I. Onoja. Metabolic syndrome in siblings of Type 2 diabetic patients in Northern Nigeria. Ahmadu Bello University/ National Postgraduate College of Nigeria. May 2008.

2. Dr I. Odeniyi. Use of low dose ACTH in assessing adrenocortical function in Nigerian patients with human immunodeficiency virus/ acquired immunodeficiency syndrome or tuberculosis. Lagos University Teaching Hospital/ National Postgraduate College of Nigeria. May 2008.

3. Dr S. Babura Mu’azu. Secondary Failure of Oral hypoglycaemic agents. (Sulphonylurea and metformin): A Study of its prevalence and risk factors among patients with type 2 DM. University of Jos/ National Postgraduate College of Nigeria. May 2008

4. Dr K. I. Akhuemokhan. Trace Mineral Status of Nigerians with Type 2 Diabetes. University of Benin/ National Postgraduate College of Nigeria. May 2008.

5. Dr O. A. Oluyemi. Prevalence of Markers of Helicobacter Pylori Infection in Diabetic Patients in Lagos. Lagos University Teaching Hospital/ National Postgraduate College of Nigeria. November 2008.

6. Mrs Oluseyi Osho. Cardiopulmonary and biochemical responses of individuals with type 2 diabetes mellitus to therapeutic exercises. University of Lagos. Ph.D Physiotherapy 2010

7. Dr Thomas Nnaji. Types and pattern of skin disorders in diabetic patients at LUTH. FMCP Part 2 November, 2010  

8. Dr Michael Akinkunmi. Occular findings in B mode ultrasonography of diabetic patients. FMCR Part 2 dissertation 2008

9. Dr Sandra Iwuala. Pattern of lipodystrophy and dyslipidaemia in patients treated with highly active antiretroviral drugs. Part 2 West African College of Physicians 2009

10. Dr C. I. Okafor. The relationship between anthropometric indices and insulin resistance among South Eastern Nigerians. Part 2 FMCP Part 2 dissertation.

11. Dr A. Adegboyega. Radiographic findings in patients with diabetes mellitus. FMCR Part 2 dissertation, 2008

12. Dr Anas Sabir. The role of anthropometric indices in the evaluation of metabolic syndrome in Northern Nigeria. Part 2 dissertation FMCP 2009

13. Dr T.H. Raimi. The role of anthropometric indices in the evaluation of metabolic syndrome in South Western Nigeria. Part 2 dissertation FMCP 2009

14. S. O. Ogedengbe

15. Dr. M. O. Olamoyegun. Impact of thiazides diuretics, alone and in combination with ACE inhibitors on glucose tolerance and beta cell function in Nigerians with hypertension 2010. FWACP part 2 disertation

16. Dr BO Ozoh. Lung function test results in patients with type 2 Diabetes Mellitus. FMCP 2009

1. Mrs Oluseyi Osho. Cardiopulmonary and biochemical responses of individuals with type 2 diabetes mellitus to therapeutic exercises. University of Lagos. Ph.D Physiotherapy 2010

2. Dr Samuel Onung. Testicular function in Nigerian men with type 2 diabetes. Part 2 National Postgraduate Medical College 2011

3. Ofem Enang. Dysglycaemia in Calabar, South East Nigeria. Prevalence and risk factors for its development. Part 2 National Postgraduate Medical College.

4. Anthony Anyanwu. Relationship between vitamin D status on glycaemia in type 2 DM patients Dr Mrs Kayode. Thyroid function and the prevalence of thyroid auto antibodies in a Nigerian diabetic population

5. Rotimi Olopade. Glycaemic load of different varieties of beans meals

6. Dr Ibegbu. Echocardiographic findings in patients with thyrotoxicosis seen at the Lagos University teaching hospital

7. Dr Nkanor. Electrocardiographic findings of diabetes mellitus

Fasanmade OA. A Study of  Insulin Sensitivity in Selected Nigerian Subjects, Dissertation in part fulfillment of the requirements for the award of the Fellowship of the West African College of Physicians (Internal Medicine). November 1996

Fasanmade OA, Ogbera AO, Chima P, Akinyemi O. Diabetes and Diet. Diabetes Healthcare Providers. August 2012